TN2010000563A1 - Fgf 21 mutants and uses thereof - Google Patents

Fgf 21 mutants and uses thereof

Info

Publication number
TN2010000563A1
TN2010000563A1 TNP2010000563A TN2010000563A TN2010000563A1 TN 2010000563 A1 TN2010000563 A1 TN 2010000563A1 TN P2010000563 A TNP2010000563 A TN P2010000563A TN 2010000563 A TN2010000563 A TN 2010000563A TN 2010000563 A1 TN2010000563 A1 TN 2010000563A1
Authority
TN
Tunisia
Prior art keywords
fgf21 mutant
polypeptides
fgf
mutants
mutant polypeptides
Prior art date
Application number
TNP2010000563A
Other languages
French (fr)
Inventor
Edward John Belouski
Murielle Marie Ellisson
Anges Eva Hamburger
Randy Ira Hecht
Yue Sheng Li
Mark Leo Michaels
Jeonghoon Sun
Jing Xu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/046113 external-priority patent/WO2009149171A2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of TN2010000563A1 publication Critical patent/TN2010000563A1/en

Links

Abstract

The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
TNP2010000563A 2009-06-03 2010-12-03 Fgf 21 mutants and uses thereof TN2010000563A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/046113 WO2009149171A2 (en) 2008-06-04 2009-06-03 Fgf21 mutants and uses thereof

Publications (1)

Publication Number Publication Date
TN2010000563A1 true TN2010000563A1 (en) 2012-05-24

Family

ID=55024645

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000563A TN2010000563A1 (en) 2009-06-03 2010-12-03 Fgf 21 mutants and uses thereof

Country Status (1)

Country Link
TN (1) TN2010000563A1 (en)

Similar Documents

Publication Publication Date Title
PH12015502433A1 (en) Fgf21 mutants and uses thereof
TN2011000161A1 (en) Fgf21 mutants and uses thereof
MY152721A (en) Fgf21 mutants and uses thereof
WO2010129600A3 (en) Fgf21 mutants and uses thereof
MX2011013903A (en) Chimeric fgf19 polypeptides and uses thereof.
MX2013005639A (en) Methods of treating fgf21-associated disorders.
SG170086A1 (en) Modified molecules which promote hematopoiesis
AP2011005814A0 (en) Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases.
MX2012004548A (en) Novel compositions for preventing and/or treating degenerative disorders of the central nervous system.
TN2010000563A1 (en) Fgf 21 mutants and uses thereof
TN2011000553A1 (en) Fgf21 mutants and uses thereof
UA102395C2 (en) Fgf21 mutants and use thereof
WO2008033374A3 (en) Ocl-2a3 compositions and uses thereof
TH158963A (en) FGF21 Mutants and their use
TN2013000211A1 (en) Methods of treating fgf 21- associated disorders